American Airlines heads into its Q2 earnings report today with options traders at their most defensive in months — and short sellers quietly rebuilding positions into the release.
The clearest pre-earnings signal comes from the options market. The put/call ratio jumped to 1.86, more than two standard deviations above its 20-day average of 1.69 — the most bearish reading since at least early June. That follows a rough stretch for the stock: down 3.2% on Tuesday alone, off 5.4% on the week, and 7.5% lower than a month ago, to close at $14.79. Short interest reinforces the cautious lean. Shorts hold 9.5% of the free float — a meaningful level — and that position has grown 4.3% over the past week after contracting sharply through June. The borrow market, however, remains wide open. Availability is running near 944%, meaning there are roughly nine shares available to borrow for every one already shorted. Cost to borrow nearly doubled in a single session to 0.79%, but it remains low in absolute terms. The lending market is not under stress; the short interest build reflects conviction, not a squeeze dynamic.
The analyst community is deeply split on where AAL goes from here. The most notable recent move came from Melius Research, which downgraded the stock to Hold on July 7 even while lifting its price target from $15 to $19 — a signal that the Street sees recovered value but questions whether the stock can sustain further gains from current levels. Goldman Sachs kept its Sell rating, raising its target to $15, essentially flagging the stock as fairly valued or stretched at today's price. On the other side, Susquehanna raised its target to $25, TD Cowen held its Buy with a $24 target, and Bernstein and Citigroup both lifted their targets into the low-to-mid $20s. The mean Street target of $19.60 implies roughly 33% upside from Tuesday's close — a wide gap that reflects genuine disagreement about AAL's debt trajectory and revenue outlook. Factor scores add one more bullish data point: EPS momentum ranks in the 99th percentile on a 90-day basis, and the 12-month forward EPS year-on-year increase scores in the 90th percentile, suggesting the earnings revision cycle has been strongly positive heading in.
Institutional ownership offers one more wrinkle. PRIMECAP Management added over 20 million shares to reach a 10.5% stake — a meaningful conviction build from an active manager. That sits alongside COO David Seymour selling roughly $2.3 million of stock in late June at prices of $17–$18, well above today's level. The insider selling is routine in context, but the gap between those execution prices and Tuesday's $14.79 close illustrates how far the stock has retreated since mid-June, when peers like UAL and DAL have held up comparatively better, each down only 2.2% and 1.0% on the week respectively.
The print will therefore test whether AAL's improving earnings-revision momentum can outweigh persistent concerns about its balance sheet and distribution strategy — and whether the stock can hold the analyst community's upgraded targets against a backdrop where options positioning and short sellers are both betting it cannot.
See the live data behind this article on ORTEX.
Open AAL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
